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ABSTRACT 
Casselbrant A. 2005. The Nitric Oxide and Renin-angiotensin II Systems in the Human 
Esophagus. Pages 1—41. Department of GastroResearch. Institute of Surgical Sciences, The 
Sahlgrenska Academy at Göteborg University, SE-413 45 Göteborg, Sweden. 
The primary function of the esophagus is to transport food boluses from the oral cavity to the 
stomach. Secondary functions are to prevent retrograde movements of the acidified gastric 
contents, but also to allow evacuation of gas. Well co-ordinated muscular activity and 
mucosa-protective mechanisms are thus pivotal for optimal esophageal functionality. Local 
mediators as well as central neural reflexes are operational alone or in combination. The 
general aim of the present thesis was to investigate two previously less studied regulatory 
systems in the human esophagus: juxtamucosal NO formation and the renin-angiotensin 
system (RAS). 
Examinations of esophageal mucosa and motor activity in vivo were performed on healthy 
volunteers. Specimens of the esophageal musculature with confirmed normal appearance 
were obtained from patients undergoing esophagogastric resection. Juxtamucosal NO 
formation was assessed using a tonometric technique. Salivary volume and titrable alkalinity 
were used to calculate alkaline secretion. Esophageal smooth muscle contractions in response 
to angiotensin II were studied using an organ-bath. Contractile events of the distal esophagus 
in vivo were assessed using multiple recordings of hydrostatic pressure and potential 
difference along a nasogastric catheter. Immunohistochemistry, PCR and the Western blotting 
were used to detect NO synthases and components of RAS. 
The results demonstrate that two sources exist for the esophageal luminal NO formation; 
chemical reduction of salivary nitrite and enzymatic degradation of L-arginine in the 
epithelium, both dependent on the presence of acid in the esophageal lumen. Salivary alkaline 
secretion increased markedly following intraluminal acid exposure and data suggest that 
intraluminal NO facilitates initiation of the acid-induced esophago-salivary reflex. Mucosal 
biopsies and muscular tissue both indicate the existence of a local renin-angiotensin system in 
the normal human esophagus. Angiotensin II stimulates the human distal esophageal 
musculature in vitro via the AT, receptor subtype, and administration of the AT, receptor 
antagonist candesartan reduces the amplitude of swallows-induced peristaltic contractions and 
the length of the high-pressure zone in vivo. 
In conclusion, the investigations show that both juxtamucosal NO formation and a local RAS 
exist in the human esophagus, and that both these regulatory systems are functional during 
physiological conditions. 
Key-words: acid, nitric oxide, nitric oxide synthase, salivary secretion, renin-angiotensin, AT, 
receptor, AT2 receptor, mucosa, smooth muscle, contractility, peristaltic, high-pressure zone, 
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ACE angiotensin converting enzyme 
Ang II angiotensin II 
AT, angiotensin II type 1 receptor 
AT2 angiotensin II type 2 receptor 
co2 carbon dioxide 
cGMP cyclic guanosine monophospate 
EDRF endothelium-derived relaxing factors 
eNOS endothelial nitric oxide synthase 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GERD gastro-esophageal reflux disease 
H+ hydrogen ion 
HCl hydrochloric acid 
HCO, bicarbonate ion 
HPZ high-pressure zone 
iNOS inducible nitric oxide synthase 
LES lower esophageal sphincter 
nNOS neuronal nitric oxide synthase 
NO nitric oxide 
NCV nitrite 
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NOS nitric oxide synthase 
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RAS renin angiotensin system 
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BACKGROUND 
The esophagus 
The esophagus is a foot-long tube that passes through the thoracic cavity, penetrates the 
diaphragm, which separates the thoracic cavity from the abdominal cavity, and joins the 
stomach a few centimetres below the diaphragm. The principal function of esophagus and its 
sphincters is to transport food and fluid from the pharynx to the stomach, and to prevent the 
reflux of gastric contents into the esophagus, pharynx and respiratory tract. Striated muscles 
surround the upper third of the human esophagus, the mid part contains both striated and 
smooth muscles, whereas the lower third consists of smooth muscle only. Esophageal 
peristaltic contractions are initiated by swallowing and are accompanied by relaxation of the 
upper and subsequently the lower esophageal sphincter (LES), to allow the passage of a food 
bolus into and through the esophagus. The swallow-induced esophageal propagated 
contraction is termed primary peristalsis, and takes about 9 sec to reach the stomach. The 
central and the enteric nervous systems jointly control the peristaltic and sphincter functions. 
Afferent fibbers from the receptors in the esophageal wall signal to the swallowing centre 
which can alter the efferent activity e.g. if food does not reach the stomach during the initial 
peristaltic wave, the distension of the esophagus activates receptors that initiate reflexes 
causing repeated contractile waves, so called secondary peristalsis. 
The lower esophageal sphincter (LES) 
The most distal part of the esophagus constitutes the lower esophageal sphincter (LES) with a 
length of 2-4 cm. This esophageal segment generates a high- pressure zone (HPZ), preventing 
gastro-esophageal reflux. The ability of the LES to maintain a mechanical barrier between the 
stomach and the esophagus is aided by the fact that its distal part lies below the diaphragm 
and is subject to the same abdominal pressures as is the stomach. If the pressure in abdominal 
cavity is raised, the pressure on both the gastric contents and the terminal segment of the 
esophagus are raised together, preventing the formation of a pressure difference that could 
force stomach contents into the esophagus. The LES generates pressure up to 80 to 90 mm 
Hg, with a resting pressure of 12 to 18 mm Hg. It is important to note that in addition to the 
esophageal musculature also other anatomical properties contribute to the sphincter 
completed. For example, the gastroesophageal valve created by the angle of His as well as the 
gastric sling musculature and particularly the crural diaphragm (Boeckxstaens 2005). 
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Reflux 
Reflux of contents from the stomach into the esophagus is a normal physiological 
phenomenon that occurs at least a few times daily in most people when the intragastric 
pressure transiently overcomes the competence of the esophagogastric junction. In healthy 
individuals, 94% of al l reflux episodes are related to so-called transient lower esophageal 
sphincter relaxation (TLESR) (Dent et al 1980, Schoeman et al 1 995, Sifrim et al 1996). 
These sphincter relaxations are not swallow-induced and they are absent during sleep (Dent et 
al 1980). The TLESRs are believed to be a normal physiological event involved in the 
mechanism of belching (Sifrim et al 1996). The regulation of spontaneous TLESRs is still 
unclear. Some investigators suggest that they are triggered by a subthreshhold pharyngeal 
stimulus, whereas others believe that gastric distension is the major triggering factor. 
Whatever the initial stimulus, spontaneous TLESRs are eliminated by blocking the vagal 
nerve, demonstrating the nature of an extrinsic reflex (Sifrim et al 1996). 
Gastroesophageal reflux disease 
Gastroesophageal reflux disease (GERD) is a term that describes a disorder caused by the 
retrograde flow of gastric (acidic) content from the stomach into the esophagus, regardless of 
whether or not signs of esophagitis are found. It is one of the most common upper 
gastrointestinal disorders, and early recognition of symptoms associated with GERD is 
important for the diagnosis and management of the disease. The pathogenesis of GERD is 
multifactorial, involving TLESRs as well as other lower esophageal sphincter pressure 
abnormalities. GERD is associated with a decrease in LES pressure, which can depend on 
anatomical abberations (i.e. hiatal herniation) or be provoked by factors such as foods (fat, 
chocolate, etc), alcohol, smoking and medications. These factors have also been shown to 
increase TLESRs. As a result, reflux of food, acid, bile, pepsin and pancreatic enzymes 
occurs, leading to esophageal mucosal injury, which in the long term can progress to Barrett's 
metaplasia and, in a minority of patients, to esophageal adenocarcinoma (Castell et al 2004). 
The esophageal muscular layers and mucosa 
The wall of the esophagus is, as well as the rest of the gut, principally organized into two 
muscular layers separated by a neuronal network (myenteric plexus). In the outer layer, the 
musculature is orientated in the axial direction (longitudinal muscle) whereas the inner layer 
is orientated transversally (circular muscle). In contrast to the gastric and intestinal parts of 
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the gut, which is constituted entirely of smooth muscle, the human esophagus contains also 
striated muscle fibbers, predominantly in the cranial part. 
The layers of the esophagus include an epithelial lining, lamina propria, muscularis mucosa, 
submucosa, muscularis propria (circular and longitudinal muscular layer) and adventitia. The 
luminal surface is covered by a non-keratinized squamous epithelium and can be separated 
structurally into three parts: a basal proliferating cell layer: stratum basalis; a mid-zone layer 
of viable metabolically active squamous cells: stratum spinosum; and a most superficial dead-
cell layer: stratum corneum (Frierson 1990). The lamina propria is curving in the epithelium 
and forms the connective tissue papillae. 
Barriers of the esophageal mucosa 
The esophageal mucosa faces an environment that can be quite aggressive. After swallowing 
food boluses, there is mechanical wear and tear, as well as heating (or even burning) or 
cooling. During reflux episodes, gastric acidic contents will exert a chemical challenge. The 
ability of the epithelium to tolerate such stress depends on the balance between the intensity 
of noxious stimulation and the protective mechanisms. Noxious substances are gastro-
duodenal contents including bile and pancreatic enzymes, but most important is refluxed 
gastric acid. It follows that most research is focused on effects and prevention of acid reflux. 
It is convenient to divide the esophageal barrier against refluxed acid into three 
compartments, the pre-epithelial barrier, the epithelial barrier, and the sub-epithelial barrier. 
The pre-epithelial barrier 
The pre-epithelial barrier consists of a mucus-bicarbonate layer and mechanical inhibition of 
reflux as well as luminal clearance mechanisms. 
Mucus bicarbonate layer. Unlike the gastric and duodenal mucosa where the surface 
epithelial cells secrete bicarbonate (HC03 ), the esophageal epithelial cell do not secrete 
HCO3". Instead, the submucosal-glands, in human located primarily in the proximal and 
middle esophagus are a source for HC03" and mucin movement into the lumen (Namiot et al 
1994, Goldstein et al 1994). These protective secretions are of particular value during sleep 
when esophageal clearance mechanisms such as swallow-induced peristalsis and salivary 
secretion are inoperative (Abdulnour-Nakhoul et al 2004). Since noxious substances act on 
the luminal side of the esophageal mucosa, the mucus bicarbonate layer is the first line of 
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defence, but in contrast to the gastric and duodenal epithelia, the mucus layer in the esophagus 
is quite thin (Quigley et al 1987). 
Esophageal clearance. There are two major factors affecting the time for clearance of acid out 
of the esophagus: esophageal peristalsis and salivary function. In the normal esophagus both 
the mechanical distension and chemical stimulus by refluxate trigger primary and secondary 
peristaltic motor activity. One peristaltic wave clears the esophageal lumen of most refluxate 
(Bremner et al 1993, Anggiansah et al 1994) but does not restore esophageal pH to a normal 
level. The restoration of pH is step-wise and related to repeat swallows, whereby each 
swallow exposes the mucosa to salivary bicarbonate thus eliminating the remaining acid by 
dilution and chemical neutralisation (Helm et al 1984, Helm et al 1982, Abdulnour-Nakhoul 
et al 2004). 
Salivary secretion. Human saliva is produced by three pairs of major salivary glands, the 
parotid, the submandibular and sublingual, and minor salivary gland structures scattered in 
various regions of the oral cavity, such as the lingual, labial, buccal, palatine, molar and 
incisive glands. Their histology reveals two distinct types of glandular morphology: 
predominantly mucous (located on the palate and tongue), predominantly serous (parotid 
glands) or mixed type salivary glands (submandibular, sublingual, glands within lips and 
cheeks (Sarosiek et al 2000). Secretion of salivary organic components is predominantly 
mediated through the adrenergic transmission, whereas water and electrolytes are mediated 
through cholinergic as well as non-adrenergic non-cholinergic (NANC) pathways mainly 
conveyed in cranial nerve VII or IX (Sarosiek et al 2000). In the awake state, salivary flow is 
continuous (about 0.5 mL /min) and carried into the esophagus by spontaneous swallows that 
occur about once a minute, but virtually ceases during sleep. Salivary secretion is greatly 
influenced by gustatory stimulation, olfactory sense, thinking of food, sensation of hunger, 
mastication, and by intra-esophageal mechanical and chemical stimulation mediated by 
esophageal-salivary reflex pathway. 
The epithelial barrier 
The structural elements of the esophageal epithelium, which are of importance for the barrier, 
consist of apical membranes, the intracellular junctions, and intercellular glycoconjugate 
material (Orlando 1994). Tight junctions hold the cells together and seal them in such a way 
that leakage of large molecules between the cells is restrained. In contrast, electrolytes and 
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small water-soluble molecular may cross these junctions. The intercellular glycoprotein 
matrix complements the barrier function of tight junctions (Orlando 2000). The buffering 
ability in the intercellular space depends on bicarbonate diffusion from blood, and protection 
against intracellular acidosis depends on the presence of basolateral membrane bicarbonate 
transport via mechanisms such as the Na+-dependent CIV HC0 3 exchanger (Goldstein et al 
1994, Tobey 1995). When the buffering capacity is overwhelmed, hydrogen ions enter the 
cells and inhibit vital cellular enzymes, including Na+-K+ ATPase, which results in swelling 
and cell death (Orlando 1994). 
The sub-epithelial barrier 
The sub-epithelial defence, acting in the submucosa, depends on the submucosal blood flow 
that is responsible for the delivery of protective agents including oxygen, metabolic substrates 
or nutrients, and bicarbonate. It also removes potentially noxious agents such as carbon 
dioxide and hydrogen ions that have entered the epithelium following reflux, along with 
metabolic by-products and cellular debris (Tobey 1995, Orlando 2000). Perfusion of the 
esophagus with acid leads to an increase in esophageal blood flow in rabbit and cat, and this 
might prevent interstitial and intracellular acidosis by increasing the delivery of bicarbonate to 
the mucosa (Tobey 1995). However, this phenomenon could not be confirmed in healthy 
human subjects (Bove et al 2005). 
VARIABLES STUDIED IN THE PRESENT THESIS 
The regulatory principles of esophageal functions are not fully elucidated. Local mediators as 
well as central neural sensory-motor controls are operation alone or in combination. This 
thesis deals with two regulatory systems, the juxtamucosal nitric oxide (NO) generation and 
the renin-angiotensin system (RAS), both briefly described below. 
Nitric oxide 
Nitric oxide (NO) is a small lipophilic and easily diffusible gas molecule. NO in biological 
systems has a short half life (3-4 seconds), so that although NO is freely diffusible, its actions 
are limited to only a few cell diameters from its site of synthesis. NO, classified as a free 
radical, is highly reactive with other molecules, preferably other radicals and oxygen and can 
form reactive nitrogen species, e.g. NO, and N203 (Beckman et al 1996, Grisham et al 2000). 
In the body, the actions of NO are restricted due to its binding to the iron of haeme in blood 
haemoglobin. Binding to metal ions in proteins is in fact a point of action for NO in many 
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signalling systems, e.g. when NO binds to guanylate cyclase in endothelial cells, leading to 
increased intracellular production of cyclic guanosine monophospate (cGMP), resulting in 
relaxation of the smooth muscle in the vessel walls (Anggard 1994). In the body NO was first 
recognised as the endothelium-derived relaxing factors (EDRF) (Ignarro et al 1987, Palmer et 
al 1987) and was soon found to be an important signalling molecule in other biological 
systems as well (Lowenstein et al 1992). 
Nitric oxide synthase 
NO is formed by degradation of L-arginine, a reaction catalysed by a family of enzymes 
called nitric oxide synthases (NOS). NOS consists of three main isoforms, two constitutive 
forms and one inducible (Moncada et al 1991, Nathan 1992). The constitutive iso-forms 
(cNOS) are mainly found in nerves (nNOS) (Garthwaite et al 1988), and endothelium (eNOS) 
(Palmer & Moncada 1989), and have been shown to require calcium for activation (Cho et al 
1992, Snyder 1995, Griffith et al 1995). The third type, the inducible NOS (iNOS) is often 
expressed in response to a challenge e.g. an infection, first identified in macrophages, and has 
shown to be calcium-independent for activation (Marietta et al 1988, Stuehr et al 1991, Cho et 
al 1992). The general view is that the two constitutive forms typically produce NO in low 
(picomolar) concentrations that exert signalling effects during physiological conditions. The 
iNOS, on the other hand, produces NO in high (nanomolar) concentrations, over longer 
periods, and is mostly associated to pathophysiological conditions (Palmer et al 1992). 
The NOS classification is, however, becoming a bit simplistic as there have been reports of 
additional NOS isoforms (Radomski et al 1991, Palmer et al 1992, Shirato et el 1998) and the 
expression of iNOS has been found during non-stimulated conditions in epithelia of paranasal 
sinuses, airways, duodenum, jejunum and kidneys (Nathan et al 1994, Lundberg et al 1995, 
Holm et al 2001, Snygg et al 2000, Guo et al 1995). 
Non-enzymatic NO production 
Non-enzymatic NO production occurs in the upper gut when luminal pH is < 3 (pKa for NO 
is about 3.2-3.4). Swallowed nitrite reacts with gastric acid and large quantities of NO are 
formed intraluminally (Benjamin et al 1995, Lundberg et al 1994, Åneman et al 1996). Such 
nonenzymatic production of NO in the stomach contributes to the defence against swallowed 
pathogens and may also be important in gastric functional regulation, e.g. gastrin release 
(McKnight et al 1997, Weitzberg et al 1998, Holm et al 2000). The salivary nitrate originates 
from dietary factors or the endogenous nitrogen turnover and is taken up from the plasma and 
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secreted by the salivary glands. In the oral cavity nitrate is rapidly reduced to nitrite by the 
bacteria flora (Tannenbaum 1976). It follows that the rate of gastric non-enzymatic NO 
formation varies considerably with the luminal nitrite load, which in turn is dependent on the 
diet and salivary secretion (Dykhuizen et al 1996, Duncan et al 1997, Vallance et al 1997). 
NO in esophagus 
The enzymatic L-arginine/NO pathway of deeper parts of esophageal tissue has been 
proposed to have a role in the neurogenic control of pe ristalsis (Yamato et al 1992, Konturek 
et al 1997), and LES relaxation (Murray et al 1991). NOS immunoreactive nerve fibres have 
been shown in the esophageal myenteric and, submucous plexa, as well as in free nerve 
endings entering the epithelium, particularly so in the lower esophagus (Rodrigo et al 1997). 
Epithelial NOS has been little investigated in the esophagus but has been associated with 
pathological conditions such as cell transformation, e.g. Barrett's metaplasia/dysplasia and 
adenocarcinoma (Wilson et al 1998). Furthermore, weak iNOS immunoreactivity has been 
reported present in the basal and parabasal layers also of normal human esophageal mucosal 
(Tanaka et al. 1999). Although, well characterised in the stomach, neither the existence, nor 
functional consequences of non-enzymatic NO formation in the reflux-acidified esophagus 
have been studied. 
The renin-angiotensin system (RAS) 
The renin-angiotensin system (RAS) is one of the body's most powerful regulators of arterial 
pressure and body fluid volumes. Reduced intake of salt and water increases the activity of 
the RAS in order to enhance sodium and water retention via direct actions on the kidneys and 
via stimulation of other hormone systems, e.g. aldosterone. Increased sodium intake inversely 
decreases the activity of the RAS to promote sodium excretion. 
RAS cascade- classical view 
Renal release of renin is stimulated by reduction of the renal perfusion pressure sensed by 
renal vascular baroreceptors in the juxtaglomerular apparatus of the afferent arteriole. Renin 
release is also stimulated by increased renal sympathetic nerve activity, regulated by 
cardiopulmonary and aortic baroreceptors and by decreased sodium delivery to the macula 
densa of the distal tubules (Laragh 1992). Angiotensinogen, mainly secreted by the liver, is 
the primary substrate for the enzyme renin and converts angiotensinogen into the decapeptide 
Angiotensin I (Ang I). Ang I has some potential direct actions, such as mild vasoconstrictor 
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properties and stimulation of catecholamine production and central nervous system (Pelayo et 
al 1981). Ang I is, how ever, mainly considered as a prohormone. The angiotensin-converting 
enzyme (ACE) is a large, zinc dependent dipeptidyl carboxypeptidases that converts Ang I 
into Angiotensin II (Ang II), which is the main effectors of most known RAS actions. ACE is 
expressed mainly in endothelial cells throughout the vasculature, as well as in a circulating 
form (Laragh 1992). ACE is not selective for Ang I and catalyses also the degradation of, for 
example, bradykinin, enkephalins, neurotensin and substance P (Corvol et al 1995). In 
addition to the key mediator octapeptide Ang II, other angiotensin I fragments have also been 
shown to be biologically active, e.g. Angiotensin (1-7), Angiotensin III and IV (Cesari et al 
2002). 
Angiotensin II receptors 
Two main Ang II receptor types have been defined in humans, the AT, receptor and AT, 
receptor. The AT, receptor is a 359 amino acid molecule with a molecular mass of 41 kDa 
(Volpe et al 2003). This receptor subtype is expressed in most organs and is ascribed the 
majority of the biological effects of Ang II; the homeostasis of arterial blood pressure, 
maintenance of electrolyte and water balance, thirst, hormone secretion, renal function and 
cellular growth in the cardiovascular system (Volpe et al 2003). 
The AT, receptor is a 363 amino acid molecule with a molecular mass ranging from 60 to 140 
kDa (due to prominent glycosylation), and has only a 33 % sequence homology with the AT, 
receptor (De Gasparo et al 2000, Volpe et al 2003). This receptor subtype is predominantly 
expressed in foetal tissue, but also in adult tissue, e.g. in brain, adrenal glands, uterus, ovaries, 
myometrium, vascular endothelium, and in pathological conditions such as stroke, skin 
wounds and vascular lesions (Volpe et al 2003). It follows that the distributions of AT, 
receptor in adults is far from being homogeneous, and may differ according to age, species, 
tissue type and pathophysiological state (Volpe et al 2003, Ewert et al 2003). The AT, 
receptor inhibits vascular and perivascular cell growth and proliferation, promotes apoptosis 
in a wide variety of cell types, and promotes cell differentiation in neuronal cell types (Volpe 
et al 2003). Thus, from several studies in adult individuals, it appears that the AT, receptor 
mediates opposing effects to those by the AT, receptor, probably in order to modulate the 
responses upon Ang II stimulating (De Gasparo et al 1999). One example of this is that AT, 
mediated vasoconstriction is counteracted by AT2 receptor induced vasodilatation. Both the 
AT, and AT, receptors are members of the G protein-coupled receptor family. AT2 
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intracellular signalling pathways have yet to be fully defined, but evidence so far indicates 
distinct differences compared to AT, signalling (Volpe et al 2003, Jackson 2001). 
Locally expressed RAS 
The traditional view of the renin-angiotensin system is that of a classical endocrine system 
with its key components associated to the renal, hepatic and lung circulations (Jackson 2001). 
However, data have accumulated during the two last decades suggesting that this is an 
oversimplification and should include also local (tissue-based) renin-angiotensin systems 
(Jackson 2001). Many tissues, including the brain, pituitary, blood vessels, heart, kidney and 
adrenal gland, express mRNAs for renin, angiotensinogen and ACE, and cultured cells from 
these tissues produce renin, angiotensinogen, and ACE (Jackson 2001). In addition to the 
potential of being a local system with dynamic expression and paracrine actions, also other 
formation pathways for angiotensins have been proposed. For example, expression of 
chymase results in Ang II formation independent on ACE (Volpe et al 2003). The biological 
significance of these unconventional angiotensin formation pathways are still not fully 
evaluated. 
RAS in the esophagus 
There exist some reports on the presence of Ang II receptors in the opossum and rat lower 
esophageal sphincter (Mykhopadhyay AK et al 1978, Fan YP et al 2002), but no information 
existed on presence of RAS within esophageal mucosa or the wall musculature in man. 
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THE THESIS 
As described above the transport of food and the protection against gastroesophageal reflux 
are primary features of the esophagus. Regulation of muscular activity and mucosa-protective 
functions are thus pivotal for optimal esophageal functionality. Local mediators as well as 
central neural reflexes are operational alone or in combination. 
The general aim of the thesis was to investigate aspects of two previously less studied 
regulatory systems in the normal human esophagus: luminal NO formation and the renin-
angiotensin system. 
The specific aims were: 
• to investigate luminal NO levels during baseline and acidic conditions and to clarify the 
sources of such NO formation 
• to clarify whether the signalling molecules NO and CO. participate in the acid induced 
esophago-salivary reflex 
• to elucidate the expression and distribution of renin-angiotensin system components in 
the mucosa and muscular layer 
• to investigate possible contractile actions by Angiotensin II on distal longitudinal and 
circular smooth muscle preparations in vitro and to clarify if endogenous Angiotensin II 
takes part in normal distal motor activity in vivo 
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METHODOLOGICAL CONSIDERATIONS 
Subjects (paper I-IV) 
Healthy subjects. Healthy volunteers (n= 39, 18-62 y, 9 females) participated in the studies. 
The subjects were Helicobacter pylori-negative as tested by the 13C-urea breath test (Hamlet 
et al 1999) to avoid the risk for interference with the L-arginine/NO pathway in the 
esophagogastric mucosa (von Bothmer et al 2002, Elfvin et al 2005). Some subjects 
participated at several occasions. 
Patients. Muscular specimens were obtained from patients (n= 11, 48-86 y, 5 females) 
undergoing radical surgery due to malignancy in the esophagogastric junction or proximal 
esophagus (usually superficial adenocarcinoma). 
Ethics. All participants had given informed consent and the study had been approved by 
Ethical Committee of Göteborg University and was performed in accordance with the 
Declaration of Helsinki. 
Intubation procedures (paper I, II, IV) 
After an overnight fast, the subjects were supplied with a nasogastric catheter of various 
designs (se below). The lower esophageal sphincter (LES) was identified using a manometric 
assembly and the catheter was placed with an infusion site positioned 15 cm above the LES. 
In some experiments one pH glass electrode was also inserted via the other nostril and 
positioned a few cm above the LES and was connected to a computer, which recorded and 
displayed pH online. 
NO measurements (paper I) 
The nasogastric catheter was supplied with a silastic balloon (tonometer) 5 cm above LES to 
measure luminal NO. The gas-permeable balloon was inflated with 5 mL of room air. 
Equilibration between NO in the intra-esophageal atmosphere and the air of the inflated 
balloon was allowed for 10 minutes. The equilibration of NO in the tonometric balloon is 
rapid reaching more than 90% of the surrounding NO concentration within 5 min (Snygg et al 
2000). The equilibrated gas was transferred into a gastight syringe and immediately injected 
into the sample line of a chemiluminescence NO-analyser (Modified Seres NOX 4000, Seres, 
Aix-en-Provence, France). The detection limit for NO was 1 ppb and calibrations were 
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performed with known concentrations of NO in N: (AGA, Stockholm, Sweden). The NO 
levels obtained by this tonometric technique thus mainly reflect NO formation in the luminal 
compartment and by the mucosa located close to the luminal compartment. During 
standardised conditions the technique exhibited an inter-sample variability of ±5% (Snygg et 
al 2000). 
Salivary samplings and bicarbonate measurement (paper II) 
The subjects were supplied with a dental suction device and instructed not to swallow. The 
saliva was collected in 10-minute fractions and the volume of each fraction recorded. Salivary 
buffering capacity (titratable alkalinity) was measured by titration with HCl to pH 2 
(Radiometer GK2320C, Copenhagen, Denmark) during vigorous stirring to remove the 
carbon dioxide formed from the reaction with HC03". The alkaline secretion was defined as 
the product of volume secretion over 10 min and titratable alkalinity. 
Bernstein-test (paper I, II, III) 
A Bernstein-test is an artificial lowering of the pH of the distal esophagus by perfusion of an 
acidic solution during 15-30 min. The test is positive if these procedures produce heartburn 
symptoms and was originally used to diagnose GERD (Bernstein & Baker 1959). In the 
present thesis a Bernstein-like procedure was used to allow investigation of acid induced 
functional changes. 
Histology (paper III) 
To assure that the mucosal biopsies and muscular tissue had a normal appearance, the 
morphological analysis was performed by an experienced histopathology's. Paraffin sections 
of formaldehyde fixed tissues were mounted on slides and stained with haematoxylin-eosin. 
In coded sections, morphometry of the esophageal epithelium was carried out using the total 
thickness of epithelium, length of papillae, and thickness of basal cell layer in relation to 
reference data. 
Western blot analysis of iNOS (paper I) 
Esophageal mucosal biopsies were taken by endoscopy, and immediately frozen in liquid 
nitrogen and stored at -80°C. The frozen specimens were sonicated in phosphate buffer 
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containing EDTA, CHAPS and proteinase blockers. After centrifugation the supernatant was 
analysed for protein content by the method of Bradford (Bradford MM 1976) and stored at 
-80°C for further analysis. Electrophoresis was run on a 3-8% tris-acetate gel on which one 
lane was loaded with prestaiiied molecular weight standards, and one lane was loaded with 
lysate from IFN-y stimulated mouse macrophage cells (RAW264.7) and served as positive 
control to iNOS. After electrophoresis, the proteins were transferred to a polyvinyl difluoride 
membrane, which was incubated with a polyclonal antibody against iNOS. An alkaline 
phosphatase conjugated secondary goat anti-rabbit antibody and CDP-Star as a substrate, 
were used to identify immunoreactive proteins by chemiluminescence and photographed. 
Data were presented as optical density per microgram of protein. 
I in in u noh istoehem ist i-y (paper I, III) 
Mucosal biopsies or muscular tissues were immediately fixed in 4% (w/v) formaldehyde in 
phosphate buffered saline (pH 7.4). Detailed descriptions are given in each paper. 
Endogenous peroxidase was quenched by 5 min incubation in peroxidase blocking solution. 
Endogenous biotin in the tissue was blocked using Biotin Blocking system (Dakopatts AB, 
Älvsjö, Sweden). The slides were pre-incubated with serum block and then incubated with 
primary polyclonal antibodies against iNOS, eNOS, nNOS, AT,, AT2 receptors or 
angiotensin-converting enzyme (ACE). Control sections were incubated with normal rabbit or 
goat IgG 0.4/<g//iL, or in some case using preabsorbed antigen instead of the primary 
antibody. Human suprarenal gland and smooth muscle served as a positive control to AT, 
receptors and iNOS, respectively. Immunoreactivity was detected by the ImmunoCruz™ 
Staining system. After being washed, the slides were incubated with biotinylated secondary 
antibody and the complex was detected using horseradish peroxidase (HRP)-streptavidin. The 
colour was developed using 3,3'-diaminobenzidine. 
Reverse transcriptase polymerase chain reaction (rtPCR) (paper I, III) 
Mucosal biopsies or muscular tissues were immediately placed in extraction solution and snap 
frozen in liquid nitrogen. Frozen tissue was homogenised and total RNA was extracted using 
phenol-chloroform extraction and ethanol precipitation. The RNA concentration was 
quantified by absorbance measurement at 260 nm and the integrity was assessed by 
absorbance measurement at 280 nm. Reverse transcription from 2.5 pi g of total RNA was 
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carried out using the SUPERSCRIPT™ First-Strand Synthesis System (Invitrogen, Lidingö, 
Sweden) with Oligo (dT) Primers. Resulting cDNA was stored at - 20°C until use. 
Polymerase chain reaction (PCR) for iNOS (paper I) 
Amplification of cDNA was performed using the Amplimer Set for human inducible nitric 
oxide synthase primers included positive control. The cycles used were 94°C for denaturation, 
62°C for annealing and 72°C for elongation and samples were then cooled. Electrophoresis of 
the products was performed on 1.5 % agarose gel containing Tris acetate/EDTA and ethidium 
bromide. A molecular weight standard was used as a molecular size standard. Visualisation of 
PCR products was achieved using ultraviolet light and images were captured. 
Real time PCR for RAS components (paper III) 
Light Cycler Q-PCR (Roche Diagnostics, Mannheim, Germany) performed the PCR reaction 
using SYBR Green I as marker and in accordance to the manufacturer's instructions. MgCl2 
concentration was optimised to 4 mM to obtain the highest signal intensity and lowest 
background. The primer sequences, Q-PCR conditions, PCR products sizes and reference are 
shown in paper III. Sample concentration was determined from a standard curve for each pair 
of primers. The quantification was performed by the software supplied by Roche Diagnostics 
(Mannheim, Germany). 
Measurements of isometric tension (paper IV) 
Resected esophageal tissue was transferred immediately to ice-cold oxygenated Krebs 
solution. The muscular layers were separated from the mucosa and circular and longitudinal 
smooth muscle strips of the distal part of the esophageal body were cut to a size of 
approximately 2 xlO mm. Each muscle strip was secured at the end with silk sutures and 
transferred to a 10 ml tissue bath containing oxygenated Krebs solution at 37°C (Letica 
Automated Organ Bath, AD Instruments Pty, Hastings, UK). The other end of the strip was 
attached to a force transducer for isometric recording of muscular activity (PowerLab®, AD 
Instruments Pty Ltd, UK). The strips were prestretched to a tension of 1 g and allowed to 
equilibrate for 30 min to develop a stable spontaneous tone. After the equilibration period, 
bethanechol, a non-selective muscarinic agonist resistant to Cholinesterase degradation (de 
Godoy et al 2002) was added at a concentration of 10 4 M to obtain a reference contraction. 
The strips were washed prior to addition of either the selective AT, receptor antagonist 
losartan (10 7and 10 5 M), or the selective AT2 receptor antagonist PD123319 (10"7and 10°M). 
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A baseline period of 15 min was allowed. Ang II was subsequently added at stepwise 
increasing concentrations (10 '"M to 10°M) every 5 min in a cumulative manner. The strips 
were washed and the experiment was finalised by another addition of be thanechol. Smooth 
muscle contractions were expressed as percent of the maximal contraction obtained with 
bethanechol (mean of the contractile response before and after the experiment). 
Multiple manometry/potential difference recordings in vivo (paper IV) 
The subjects were supplied with a nasogastric catheter (Chl2) with 15 sideholes at 1 cm 
interdistance (customised E57, Dentsleeve International LTD, Mississauga, Canada). The 
catheter was fixed to one nostril and positioned so that it straddled the esophagogastric 
junction leaving 4-5 side holes in the gastric lumen and the rest in the distal esophagus (Fig 1, 
left panel). Each side hole was connected to a pressure transducer that was separately fed with 
a low flow (3 mL h"1) of 150m M NaCl. In addition, each pressure recording line (electrically 
isolated from each other) was used as an electrode for electrical potential recording via an 
Ag/AgCl bridge connected to a high-impedance voltmeter with a reference electrode 
positioned subcutaneously. Thus, both the intraluminal hydrostatic pressure and transmucosal 
electrical potential difference (PD) at each side-hole was displayed on-line and stored for later 
analysis on a Macintosh personal computer (Apple Computers, CA, USA) using specially 
designed software (Labview, National instruments, Austin, USA). The side hole recordings 
were plotted as a function of the distance from the nostril thus allowing simultaneous 
identification of 1. / the pressure profile along the distal esophagus and esophagogastric 
junction; and 2. / the position of the step-up in PD from esophageal mucosal values (typically 
12-15mV) to that of gastric mucosa (typically 25-50mV) (Fig 1, right panel). The PD step-up 
allowed a continuous identification of the position of the esophagogastric mucosal transition 
zone in relation to the nostril, a changed distance indicating axial movements of the 
esophagus. In addition, the subjects were supplied with a dental suction device and instructed 
to avoid swallowing. Submental electromyography was used to identify voluntary and 
involuntary swallowing episodes and was recorded and stored as described above. 
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Figure 1 
Left panel: Illustration of the multiple manometry and potential difference (PD) catheter used in the in-vivo 
study. The hydrostatic pressure and PD were recorded at 15 side holes (interval: 1 cm) straddling the 
esophagogastric junction. Right panel : The potential difference (PD) recordings were displayed as a function of 
distance from nostril. A step-up of PD values indicates the transition from esophageal squamous to gastric 
columnar mucosa (corresponding to the endoscopic Z-line). Since the nasogastric catheter is fixed to one nostril, 
movements of the PD step-up along the x-axis indicate axial movements of the esophagus. (The simultaneous 
esophageal manometric recordings are not shown in the figure.) 
Principle behaviour of transmucosal potential difference 
All the epithelia in the digestive tract, including that of the esophagus, exhibit a transmucosal 
electrical potential difference (PD). Even if different ions are implicated in the generation of 
PD, its principal source seems to be the transport of chloride and sodium ions from one side 
of the epithelia to the other. The result of these phenomena is a separation of charges across 
the epithelium so that the luminal surface has excess negative charges and the serosal surface 
has excess positive charges. In the esophagus this separation of charges is achieved by active 
transport of sodium from the lumen to serosal surface. Since the active transport of sodium is 
relatively fast compared with the passive diffusion of chloride ions, the net result is a greater 
number of positive charges on the serosal surface and a greater number of negative charges on 
the luminal surface. In the stomach additional ions are involved in the generation of PD e.g 
potassium, sodium, bicarbonate and its principal source seems to be the active transport of 
chloride ions (Schwartz et al 1987, Scarpignato et al 1995). Disruption of the mucosal barrier 
by the so-called "barrier breakers" such as ethanol, aspirin, and bile is associated with a 
decrease in PD (Scarpignato et al 1995). Presence of H+ in the lumen will also influence PD in 
a biphasic manner: an initial increase in PD is followed by a return towards the baseline 
within 30 min (Scarpignato et al 1995). The first in PD change is considered to be a result of 
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increased H+ ion diffusion from the lumen to serosa and the fall in PD reflects the back 
diffusion of ions (Orlando et al 1981, Jacobson et al 2002). 
Drugs and chemicals (paper IV) 
The following chemicals were used in the in vitro study: Angiotensin II, bethanechol chloride 
and the AT, receptor antagonist PD123319 (Sigma Chem. Inc., St Louis, MO, USA); AT, 
receptor antagonist losartan (Merck, Whitehouse Station, NJ, USA) were all dissolved in 
Krebs solution. In the human study 16 mg of the angiotensin II type 1 receptor antagonist 
candesartan (Atacand®, AstraZeneca, Mölndal, Sweden) was ingested 10-12h prior to 
investigation to obtain optimal plasma concentration and ATt receptor inhibition (Gleiter et al 
2002, Azizi et al 2004). 
Statistics (paper I-IV) 
Differences in NO formation between groups in paper I were identified using ANOVA and 
Fisher's PLSD. Significant differences for multiple dependent groups of data in paper II were 
identified using Friedman s two-way analysis of variance and contrasted by the Wilcoxon 
signed rank test. In papers III and IV, significant differences between multiple independent 
groups of da ta were identified using the Kruskal-Wallis and contrasted by the Mann-Whitney 
U test. In paper IV, significant differences for dependent group of data were identified using 
the Wilcoxon signed rank test. Calculations were processed by Statview 4.1 (SAS Institute 
Inc., Cary, NC, USA). A p-value y0.05 was considered to be statistically significant. Unless 
otherwise stated, values are given as means ± SEM. 
For tension recording studies in paper IV, the amplitude of contraction was standardised as 
the percentage of the contraction induced by lxlO 4 M bethanechol. Differences between 
groups were determined based on EC^ values defined as the concentration Ang II producing 
50% of the maximal response as interpolated from the individual concentration response 
relationship, in the presence or absence of the antagonists. Individual values of contractile 
events in vivo were calculated as means of the number of recorded events (usually 3 wet 
swallows, 6-8 dry swallows and 2-4TLESRs). Basal values were defined as 2-10 min stable 
conditions without swallowing or TLESR activity recorded at least 3 times during the course 
of an examination and presented as mean of these recordings. 
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RESULTS AND COMMENTS 
INVESTIGATION OF NITRIC OXIDE SYSTEM (PAPERS I AND II) 
Measurement of luminal NO formation (paper I) 
Swallowing of nitrite-containing saliva into the acidic stomach results in formation of large 
quantities of NO. Therefore, there are good reasons for believing that similar high NO levels 
occur also in the esophagus when swallowed saliva meets an acid reflux. 
The nitrite concentration in saliva is highly dependent on nitrate intake (Tannenbaum et al 
1976). Dietary precautions had to be taken into account before assessing the intraluminal 
esophageal NO forming capacity. The volunteers were instructed to avoid nitrate-rich food 
(vegetables, spicy, smoked or pickled food) during the three days preceding the examination. 
During baseline conditions intraluminal pH was neutral and no intra-esophageal NO was 
detected. Furthermore, the absence of NO formation was independent of whether the saliva 
was swallowed or whether it was diverted from the oral cavity by a suction device (Fig 2, 
panel a). 
During esophageal infusion of acid over 30 min, giving an intraluminal pH of around 1, the 
NO levels rose dramatically to around 12 000 ppb. This high rate of NO formation in the 
presence of acid fell by 95% following the deviation of saliva (Fig 2, panel a). Thus, these 
experiments showed convincingly that intraluminal NO formation was saliva and acid 
dependent. 
In a separate series of experiments, the subjects ingested a solution containing 200 mg 
potassium nitrate 40 min before instrumentation. The amount of nitrate is comparable to 
eating a large lettuce meal and the procedure has previously been shown to raise the salivary 
concentration of nitrite to sub-maximal physiological levels (Weitzberg et al 1998). NO 
formation was almost doubled during acid perfusion compared to the experiments without the 
nitrate load. Compared to the baseline experiments with low nitrate intake, the nitrate-loaded 
individuals showed some NO production also during pH-neutral conditions (Fig 2b), although 
this difference did not reach statistical significance. When the saliva was diverted, esophageal 
NO levels were negligible during pH-neutral conditions. During acid perfusion, however, NO 
increased to approximately 5000 ppb (Fig 2b), i.e. fivefold that observed without a nitrate 
load (Fig 2a). 
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Panel a. The esophageal NO formation in healthy 
volunteers (n=5) after three days of low nitrate diet. 
Measurements were performed during baseline (pH 7) and 
after 30 min of acid perfusion (pH 1). The procedure was 
repeated during salivary deviation on a second study day. 
The subjects were then supplied with a dental suction 
device and were instructed not to swallow. Panel b. Nitric 
oxide output after an acute nitrate load (200 mg potassium 
nitrate solution 40 min before the examination, n=5). NO 
formation was measured during baseline (pH 7) and after 30 
min of acid perfusion (pH 1), without or with salivary 
deviation. 
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Taken together the experiments demonstrated that a nitrate rich diet contributes to an 
increased esophageal NO formation capacity, provided that the lumen is acidified. However, 
it was obvious from the experiments that NO also occurred to some degree during salivary 
deviation and acid conditions. It was suspected that the salivary deviation was insufficient and 
that small amounts of saliva reached the acidified part of the esophageal lumen. 
In order to avoid acid-dependent NO formation completely, the lumen was rinsed by infusion 
of saline and pH was allowed to return to above 5 as confirmed by simultaneous pH-metry. In 
these experiments, 30 min after the termination of the acid perfusion a substantial NO 
response persisted in most cases. This was not the case following control perfusion with 
saline. The interpolation of these results was that some juxtamucosal NO formation still 
occurs also when non-enzymatic NO formation cannot, by definition, take place. 
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Mucosal biopsies were taken after the experiments and immunohistochemistry revealed a 
distinct staining for iNOS in the esophageal squamous epithelial cells in all biopsies, whereas 
immunoreactivity for eNOS and nNOS was not observed. Western blot analysis of the 
esophageal mucosal tissue confirmed the presence of a 130 kD protein corresponding to 
iNOS. Furthermore, additional support for the presence of mucosal iNOS was obtained using 
RT-PCR, which detected iNOS mRNA in all the biopsies tested. These findings indicate that 
some NO is formed upon luminal acid exposure also by the L-arg/NO pathway in the 
esophageal epithelium. 
In conclusion, it is evident that intra-esophageal NO formation is a prominent phenomenon 
provided that the lumen is acidified. The bulk of luminal NO originates from reduced nitrite, 
but a small portion is very probably a product of degradation of L-Arg by epithelial iNOS. 
Regulatory function of luminal NO and C02 (paper II) 
Mucosal irritation by acid activates the oral salivary glands via the esophago-salivary reflex. 
It has been suggested that impairment of this mucosa protective reflex contributes to gastro­
esophageal disease (Sonnenberg et al 1982). In paper II, we explored some aspects of the 
triggering stimuli that elicit the esophago-salivary reflex. One obvious stimulus for such 
alkaline salivation is the acid itself. However, there are theoretically two acid-dependent 
molecules with messenger potential in the esophageal lumen: carbon dioxide (C02) formed 
when refluxed hydrogen ions (H+) meet bicarbonate in swallowed saliva; and, as discussed 
above, NO that is formed when salivary nitrite reacts with acid-reflux: 
HCO, +H+y CO2 + H2O 
N02" + H+Y Y NO 
We investigated whether the signalling molecules NO and C02 participated in the regulation 
of salivary volume secretion and neutralising capacity in response to luminal acid exposure 
(modified Bernstein-test). 
Salivary secretion is greatly influenced by gustatory stimulation, olfactory sense, thinking of 
food, sensation of hunger, mastication, and by intra-esophageal mechanical and chemical 
stimulation and it was not surprising that baseline salivary volume secretion and titratable 
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alkalinity differed markedly between individuals, ranging between 3.6 and 51 mL/10 min, and 
6.0 to 36 mEq/L respectively. It follows that the calculated alkaline secretion ranged between 
4.2 and 143 /(Eq/min (median = 20.0 /<Eq/min, 48 measurements). 
Intra-esophageal acidification induced a prompt increase in both salivary volume and 
alkalinity. Furthermore, salivary volume secretion increased significantly more when nitrite 
was added in comparison with acid alone, particularly during the first 10 min. Additions of 
bicarbonate alone, or together with nitrite, tended to decrease the salivary volume secretory 
response. Importantly, the alkalinity of the saliva was not altered by addition of nitrite or 
bicarbonate. It follows that the salivary alkaline secretion increased upon exposure due to 
increased volume secretion only. The initial part of this response was significantly larger in 
the presence of nitrite compared to acid alone. This was not observed when bicarbonate was 
added or nitrite and bicarbonate were given in combination (Fig 3). The addition of 
bicarbonate to the acid-solution will somewhat increase the pH in the solution an effect that 
reduces the acid load and possibly the stimulus. However, the addition of nitrite also 
neutralises hydrogen ions when NO is formed, but in this case a significant salivary 
stimulation occurred. The stimulus thus appears to be related to NO rather than to pH. 
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Figure 3 
The salivary alkaline secretion in response to a single 
(20 min) intraluminal acid exposure with lOOmM(D) 
acid (n=9), (•) acid+nitrite (n=9), (•) 
acid+bicarbonate (n=8). (Oi acid+ nitrite + 
bicarbonate in combination (n=8) in human 
esophagus. The data shown is expressed as mean 
values ± SEM and represents the mean percentage 
change from baseline. *P<0.05, significant difference 
between groups (Wilcoxon signed rank test). 
The continuous infusion of acid used in the Bernstein test (20 min) does not mimic the short 
lasting pH-deflections that occur upon endogenous gastroesophageal reflux. We therefore 
tested whether the salivary responses to two separate acid exposures differed from the one 
obtained after a long-lasting acidification of similar total duration. Unlike the comparable first 
10 min expression in the previous experiments, the short (10 min) acid exposure stimulated 
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neither salivary volume secretion nor titratable alkalinity (n=7). The reason for this difference 
is not known. However, when nitrite had been added to the acid solution, volume secretion 
increased transiently with a peak reaching +22 ± 2.6% compared to baseline, but titratable 
alkalinity remained largely constant. It follows that the first 10 min acidification raised 
salivary alkaline secretion only in the presence of nitrite (p<0.05) (Fig 4). 
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Figure 4 
The salivary alkaline secretion in response to a 
repeated 10 + 10 rain i ntra-esophageal acidification 
with lOOmM(D) acid (n=7) or (•) acid+ nitrite(n=7) 
in a human esophagus. The data shown are expressed 
as mean values ± SEM and represents the mean 
percent change from baseline. *P^0.05, significant 
difference between groups (Wilcoxon signed rank 
test). 
This confirming the finding that presence of nitrite accelerates the induction of the esophago-
salivary reflex. Upon a second intraluminal acidification performed 30 min after the first one, 
salivary alkaline secretion increased markedly, regardless of the presence of nitrite (Fig 4). 
The accumulated salivary alkaline secretion during 70 min following a single 20 min intra-
esophageal acid exposure ranged between 107 to 398 /t Eq. In quantitative terms this response 
was similar to the one obtained when the acidification was divided into two separate periods 
of each 10 min. In conclusion, nitrite (NO formation) accelerated the induction of the 
esophago-salivary reflex. The absolute magnitude over time of the salivary alkaline response 
was independent on if acid expression was continued or intermittent (10+10 min). 
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INVESTIGATION OF RENIN ANGIOTENSIN II SYSTEM (PAPERS III AND IV) 
Expression of the renin-angiotensin system (paper III) 
In paper III, we explored the presence of RAS components in the normal human esophageal 
body. Only volunteers with no history of even mild gastroesophageal reflux disease and with 
normal mucosal appearance at endoscopy and histological analyses were included. The 
muscular specimens of the distal esophageal body were taken from patients with malignant 
disease. Precautions were taken not to include tissue in close relation to the pathological 
process as assessed macroscopically and confirmed by normal histological appearance. 
Real-time qPCR analysis of the esophageal specimens, mucosa and muscular tissue, all 
showed existence of RNA indicating transcription of angiotensinogen, renin, ACE, ATj 
receptor and AT, receptor genes. 
Immunohistochemistry performed on mucosal biopsies revealed a distinct staining for the AT, 
receptor in the epithelium and most obvious in the stratum basale and stratum spinosum. AT[ 
receptor immunoreactivity was also detected in the blood vessel walls supplying the 
epithelium and in the lamina propria Immunostaining for AT-, receptors was detected in the 
epithelium and most distinctly in stratum spinosum and in blood vessel wa lls supplying the 
epithelium in the lamina propria. Immunoreactivity for ACE was found in the capillary walls 
located at the tip of the papillae and in the blood vessel walls in the lamina propria. 
Immunohistochemistry performed on muscle tissue samples revealed a distinct staining for 
AT, receptor in the muscular bundles and in the wall of the small blood vessels close to the 
muscle cells. Immunoreactivity for AT2 receptor was faint in the muscle cells, but was 
observed in blood vessels wall. ACE immunostaining in the muscular tissue was also found in 
the vessels wall. 
The results strongly indicated the existence of a local renin-angiotensin system in the normal 
human esophageal mucosa and wall musculature. The localisation of ACE and Ang II 
receptors indicated an Ang Il-formation in both the mucosa and the musculature. 
Angiotensin II and esophageal muscle (paper IV) 
In paper IV, we focused on potential muscular action by Ang II, particularly contractile 
actions and related receptor pharmacology. 
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Ang II caused a concentration dependent rise in tension of both longitudinal and circular 
smooth muscle preparations in vitro. The maximal increase in longitudinal smooth muscle 
tone was 17.9 ± 3.6% (ECJ0 value = 1.2 ± 0.4 xlO 7 M Ang II) and for circular smooth muscle 
23.4 ± 4.3% (EC» value = 1.0 ± 0.4 xlO 7 M Ang II) of the bethanechol reference contraction. 
The AT, receptor antagonist losartan at 105 M abolished Ang II induced contractions. At a 
concentration of 10"7 M losartan caused a significant rightvvard shift of the concentration-
response curve in both the longitudinal (FC,, value = 7.3 ± 1.0 xlO 7M; PcO.Ol) and the 
circular (EC50 value % 1.4 ± 0.6 xlO "6M; P<0.01) smooth muscle as compared with Ang II 
alone (Fig 5a). In contrast, the AT2 receptor antagonist PD123319 (10 7M or 10~5M) caused no 
significant modification of concentration response curves by Ang II, neither in the 
longitudinal (EC50 value = 2.0 ± 0.7 xlO 8M) nor in the circular (EC50 value = 1.4 ± 0.5 xlO 8  
M) muscle preparations (Fig 5b). When losartan and PD123319 were added in combination 
the response curve was generally similar to when losartan was given alone (data not shown in 
figure). 
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Figure 5 
Concentration-response curve 
showing the contractile effect of Ang 
II (•) in the human longitudinal (18 
strips from 9 patients) smooth 
muscle. Panel a: treatment with the 
ATj receptor antagonist losartan 107  
M (•) and 1(T5 M (•) (5 and 7 strips 
from 3 and 4 patients, respectively). 
Panel b: treatment with AT2 receptor 
antagonist PD123319 10 M (•) and 
105 M (•) (5 and 7 strips from 3 
and 4 patients, respectively). Data 
are plotted as means±SEM. 
The in vitro experiments provided evidence that Ang II mediates AT, receptor dependent 
contractions in both longitudinal and circular smooth muscle of the distal human esophagus. 
These results evoked the question if endogenous Ang II takes part in distal esophageal motor 
activity in vivo. The latter was assessed by recording esophageal contractile events in healthy 
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volunteers with or without pre-administration of candesartan. This compound was ingested as 
a single dose of 16 mg 10-12 h before recordings to obtain an optimal AT! receptor 
interference (Azizi et al 2004, Gleiter et al 2002). We measured the following contractile 
events: the amplitude of primary (swallow induced) peristaltic wave; swallow-associated axial 
shortening of the esophagus; the tonic LES pressure and length of the HPZ; and the reinforced 
contraction in LES that occurs after a transient lower esophageal sphincter relaxation 
(TLESRs elicited by air distension of the stomach). 
Voluntarily induced swallowing induced a typical propulsive contraction that peaked at the 
distal part of the esophagus immediately after that the high-pressure-zone had vanished and a 
retraction of the PD step-up had occurred. By comparison, peak-pressures were significantly 
lower following dry swallows in presence of candesartan (p<0.05), and tended to be lower 
also following wet swallows, but that difference did not attain statistical significance. The 
length of oral retraction of the PD step-up was similar independent of treatment with 
candesartan (Table 1). 
The LES was visualized as a 2-4 cm high-pressure zone (HPZ), and the length of the HPZ 
was significantly shorter in presence of candesartan (p<0.05). The basal pressure of the HPZ 
was 16-20 mmHg above intragastric pressure and tended to be lower after candesartan, but 
that difference did not attain statistical significance (Table 1). Insufflation of 500 ml air into 
the stomach induced transient relaxations of the LES allowing gas evacuation (belching). The 
TLESR was followed by a profound contraction that after 10-30 s was reduced to a sustained 
HPZ with more moderate intraluminal pressure. The peak pressure of the "post belch" 
contraction" in the LES was of a similar order of magnitude with or without candesartan 
treatment (Table 1). 
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Table 1. Contractile activity in distal esophagus of healthy volunteers (n=7) at two separate study days in the 
absence (control) or presence of an angiotensin II type I receptor antagonist (candesartan; Atacand® 16 mg p.o. 
administered 10-12 h prior to recordings). 
Control Candesartan 
Primary peristalsis, manometry 
Peak pressure (mm ! Ig) 
Dry swallow 
Wet swallow 
80.9 ± 6.5 
87.4 ± 12 
-24 % ± 7.4 (#) 
-12 % i 13.7 
Primary peristalsis, axial movements 
PD step up retraction (cm) 
Dry swallow 
Wet swallow 
2.3 ± 0.3 
2.3 ± 0.3 
+8 % ± 17.4 
-13 %± 17.4 
LES 
LES basal tone (mm Hg) 
Basal HPZ length (cm) 
Post-TLESR contraction 
(mmHg) 
18.3 ±3.7 
3.1 ±0.14 
65.3 ±6.1 +7 % ± 10.9 
-27.6 % ± 14.2 
-18.2% ±5.5 (#) 
Definitions: PD= potential difference; HPZ=high-pressure zone; LES= lower esophageal sphincter; TLESR= 
transient lower esophageal sphincter relaxation. 
These in vivo results indicate that Ang II is involved in esophageal contractions via the AT, 
receptor. Furthermore, our data suggest a differential involvement of Ang II in the co­
ordination of distal esophageal contractile events influencing primarily the circumferential 
contractions that create peristaltic pressure-waves in the esophageal body and the HPZ in the 
LES region. 
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CONCLUSIONS 
The following conclusions were drawn from Paper I to IV: 
• two sources exist for esophageal luminal NO formation, both dependent on the 
presence of acid in the esophageal lumen: 1) non-enzymatic chemical reduction of 
salivary nitrite, a mechanism related to dietary intake of nitrate, 2) enzymatic NO-
generation by iNOS expressed in the epithelium 
•esophageal intraluminal NO facilitates the acid-induced esophago-salivary reflex 
whereas, intraluminal CO, seems to have negligible effect 
• there exists a local renin angiotensin system in normal human esophageal mucosa 
and wall musculature 
•Angiotensin II mediates an AT, receptor dependent contractile effect on the smooth 
muscle of the distal human esophagus 
•Angiotensin II exert differential effects in the co-ordination of dis tal esophageal 
contractile events influencing primarily the circumferential contractions that create 
peristaltic pressure-waves in the esophageal body and the HPZ in the LES region 
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GENERAL DISCUSSION 
The results demonstrate that two sources exist for the esophageal luminal NO formation; 
chemical reduction of salivary nitrite and enzymatic degradation of L-arginine in the 
epithelium, both dependent on the presence of acid in the esophageal lumen. Salivary alkaline 
secretion increased markedly following intraluminal acid exposure and data suggest that 
intraluminal NO facilitates initiation of the acid-induced esophago-salivary reflex. Mucosal 
biopsies and muscular tissue both indicate the existence of a local renin-angiotensin system in 
the normal human esophagus. Angiotensin II stimulates the human distal esophageal 
musculature in vitro via the AT, receptor subtype, and administration of the AT, receptor 
antagonist candesartan reduces the amplitude of swallows induced peristaltic contractions and 
the length of the high-pressure zone in vivo. 
Juxtamucosal NO formation 
Nonenzymatic NO production occurs in the stomach when luminal pH is < 3 (pKa about 3.2-
3.4). Swallowed nitrite reacts with gastric acid and large quantities of NO and other nitrogen 
species, e.g. N02 and N,03 are formed intraluminally (Benjamin et al 1994, Lundberg et al 
1994, Åneman et al 1996, McColl 2004). The present investigation (I) shows that such non­
enzymatic intraluminal NO formation occurs also in the esophagus in case of acid reflux. The 
results also suggest that NO is locally produced by NO-synthases within the squamous 
epithelium in response to acid exposure. Epithelial NOS has been little investigated in the 
esophagus and has been associated with pathological conditions such as cell transformation, 
e.g. Barrett's esophagus and adenocarcinomas (Wilson et al 1998). Furthermore, Tanaka et al. 
(1999) have shown that weak iNOS immunoreactivity is normally expressed in the basal and 
parabasal layers of esophageal mucosal squamous epithelium. Recently Bove et al (2005) also 
described juxtamucosal enzymatic NO formation in ferret esophagus and suggested a function 
related to epithelial integrity. 
The finding of salivary (nitrate) dependent NO formation in the acidified esophagus is of 
particular interest. Nitrate is a natural component (an essential plant nutrient) of all cereals, 
fruit and vegetables, and green plants organs (e.g. spinach leaves) usually contain the highest 
concentrations (Duncan et al 1997). That study also showed a dietary dependent NO 
formation related to nitrate intake. The role of this chemically derived NO formation in the 
stomach is probably to take part in the luminal gastric defence against swallowed pathogens 
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(Dykhuizen et al 1996) and to be an acidity-signalling factor for mucosal functions e.g. 
gastrin release (Holm et al 2001). 
The present study (II) demonstrated that intra-esophageal NO formation may have a 
signalling function in the mediation of salivary volume in response to luminal acidity. 
Salivary secretion has previously been shown to increase after acid exposure (Helm et al 
1984, Dutta et al 1992). In the present study it was observed that the addition of nitrite in the 
acid solution accelerated the onset of the initial 10 min part of the salivary secretion response. 
This initial part of acid-exposure is the most relevant with regard to real gastro-esophageal 
reflux, which seldom exceeds a few minutes. 
The general opinion regarding the induction of the esophago-salivary reflex is that the 
presence of acid on the surface of the esophageal mucosa results in the diffusion of hydrogen 
ions through the thin mucus-buffer layer into the mucosa. The lowered intramucosal pH then 
stimulates chemoreceptors of the submucosal nerve plexus. The chemoreceptors will convey 
the stimulatory signal via the afférents to the CNS and activate a reflex stimulation of salivary 
secretion (Sarosiek et al 2000). NO is a good signalling molecule, and it may be speculated 
that juxtamucosal NO activates neural reflexes or the release of other agents from the 
epithelium. NO may actually be an intermediate messenger between luminal acidity and 
mucosa protective mechanisms. Such activation of mucosal protection in response to luminal 
acidity has previously been reported regarding duodenal mucosal alkaline secretion in rat and 
pig duodenum as well as the acid dependent inhibition of gastrin release from the human 
antrum (Holm et al 1997, 1998, 2000, 2001). The topographical organisation of the nitric 
oxide synthase in the epithelium in combination with luminal non-enzymatic NO, may create 
particular conditions for NO gradients through the mucosa (fig 6). 
Figure 6. 
Hypothetical depiction of NO gradient through the 
esophagus epithelium. Intra-epithelial NO 
formation by the L-arg/NO pathway may be 
activated by H+ diffusion and salivary (nitrate) 
dependent NO formation, immediately formed 
upon luminal acidification create a NO 
concentration gradient through the epithelium 
serving for induction of the esophago-salivary 
reflex via afferent nerve. 
ESOPHAGUS LUMEK 
NO gra&ieat 
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If NO is a main contributor to the activation of a subepithelially located afferent receptor it is 
important to consider the kinetics and short distance of action of this molecule. Acid induced 
intra-epithelial NO formation by the L-arg/NO pathway have some lag time due to restricted 
H+ diffusion in the epithelium, but could then be quite long lasting, thus persisting also after 
that the luminal stimulus (H+) has been eliminated. Non-enzymatic NO formation, on the 
other hand, is instantly formed upon luminal acidification. Theoretically it creates a marked 
concentration gradient through the epithelium even before tissue pH is lowered. It follows that 
the esophago-salivary reflex is initiated before that the epithelium is acidified. 
Simultaneously with non-enzymatic NO formation also C02 is generated in the neutralising 
reaction between hydrogen ions and bicarbonate; the latter being present in both the saliva 
and submucosal glands secretion. Previous studies have shown that C02 acts as a mediator of 
the acid-induced increase in duodenal mucosal alkaline output in rats (Holm et al 1998). In 
the present study (II), a C02-containing acid solution exposing the esophageal mucosal had no 
clear-cut effect on the salivary response. Also the combined presence of bicarbonate and 
nitrite in the acid solution was without effect, suggesting an inhibitory action of CO, on the 
initiation of the esophago-salivary reflex. Recently it was shown that NO and C02 may act in 
an opposing direction. Holm et al (2001) showed that acid-induced inhibition of meal-
stimulated gastrin release is partly dependent on NO generated from swallowed salivary 
nitrite, whereas CO, instead seems to potentiate gastrin release. The present experiments on 
C02 cannot be regarded as conclusive and further studies are needed to fully understand the 
relative effects of C02 and NO in the esophagus. 
In the situation of gastro-esophageal reflux disease (GERD), patients often report aggravated 
symptoms related to certain food ingredients, several of them having high nitrate levels 
(Nebel et al 1976). A variety of factors have been shown to decrease the lower esophageal 
sphincter, including fatty foods and alcohol (Nebel et al 1976). Based on the finding in (I) 
and (II) it is tempting to suggest that juxtamucosal NO formation plays a role in GERD. Bove 
et al (2003) showed that nitrate supplementation had no significant effect neither on the 
sphincter resting tone nor on motor function in healthy volunteers or in GERD patients. 
However, the acute nitrate load, used by Bove et al (2003) increased the nitrite in saliva only 
marginally from basal value of approximately 2 /<M to 12 /(M, and additional studies with 
repeated nitrate dosing are desirable. 
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Nitric oxide in high doses is known to be mutagenic due to the fact that NO reacts with 
oxygen to form N203 which can damage DNA directly or indirectly via generation of N-
nitroso compounds (McColl 2004). The major factor preventing the formation of N-nitroso 
compounds from nitrite entering the acidic stomach is ascorbic acid, which is actively 
secreted in human gastric juice as well as being present in most ingested foods. Ascorbic acid 
has also been suggested to be present in saliva (McKnight et al 1997). 
Although the harmful and potentially carcinogenic activity of N- nitroso compounds cannot 
be dismissed, epidemiological evidence for this association is principally lacking (Duncan et 
al 1997, Dukhuizen et al 1996, McColl 2004). It seems unlikely that luminal NO formation 
per se, being a physiological event in the stomach and at least occasionally in the esophagus, 
should contribute significantly to carcinogenesis. To be carcinogenic it is reasonable to 
assume that an inflammation has to be simultaneously present with generation of oxygen 
radicals like superoxide. NO and superoxide can form peroxynitrite which in turn is highly 
cytotoxic and mutagenic (Grisham et al 2000). 
RAS in the esophagus 
The present investigation (III) also demonstrated the existence of a local renin-angiotensin 
system in human esophageal mucosa and wall musculature. 
The traditional view of the renin-angiotensin system is that of a classical endocrine system 
with its key components associated to the renal, hepatic and lung circulations (Jackson 2001). 
However, data have accumulated during the last decades suggesting that there exist also local 
(tissue-based) renin-angiotensin systems (Jackson 2001). The expression analyses in the 
present study showed gene transcripts for angiotensinogen, renin, ACE, AT! and AT2 receptor 
both in the esophageal mucosa and wall musculature. These data strongly suggest that a local 
RAS is operational in the human esophagus. 
The biological actions of RAS are largely related to the effects of the octapeptide angiotensin 
II (Ang II) and its binding to specific receptors, the AT, and AT2 receptors (de Gasparo et al 
2000). Furthermore, many actions mediated by AT, receptors are inhibited by concomitant 
binding of Ang II to the AT2 receptor (if present) (de Gasparo et al 2000). 
Ang II has been shown to exert potent contractile effects via AT, receptors in different 
gastrointestinal smooth muscles such as rat and opossum lower esophageal sphincter and in 
guinea pig ileum, gastric fundus and gall bladder (Mukhopadhyay et al 1978, Leung et al 
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1993, Fan et al 2002, de Godoy et al 2004). The present in vitro experiments (IV) 
demonstrated that Ang II has a marked contractile effect both on longitudinal and circular 
smooth muscles of the distal esophageal body. Furthermore, sensitivity to losartan indicates 
mediation through the AT receptor. On the other hand, the AT, receptor antagonist 
PD123319 had no significant effect on Ang II-induced contraction. That finding is supported 
by our previous morphological evaluation demonstrating that only the AT, receptor subtype is 
localised in the muscle cells. 
However, it should be noted that AT, receptor expression might vary according to tissue 
conditions. For example hypoxia and inflammation promote AT2 expression and may differ 
according to age, species, tissue type and pathophysiological state (De Gasparo et al 1999). It 
remains to be tested if there exists conditions where AT2 receptor expressions are altered and 
if this is associated with an altered response to Ang II. 
The control of esophageal motility has a complex organisation involving extrinsic innervation 
and local reflex arcs. In addition to classical excitatory (e.g. acetylcholine) and inhibitory (e.g. 
VIP, nitric oxide) neurotransmitters a number of co-transmitters have been postulated to be 
involved (Wörl J 2005). Also, the mechanisms of peristaltic control are different between 
striated and smooth muscle, yet the peristaltic contraction sweeps from one to the other 
muscle type without a detectable break (Wörl et al 2005). 
Half of the muscle mass in the esophagus and, in the entire digestive tract, is composed of a 
longitudinal muscle layer, yet its role in gastrointestinal tract motility and bolus movement is 
not well understood, partly because of the difficulty in recording its function. Recently studies 
using ultrasound imaging have defined longitudinal muscular contractions on the basis of the 
law of mass, as an increase in muscular thickness without a concomitant luminal pressure 
increase (Nicosia et al 2001, Mittal et al 2005). In the present in vivo experiment (IV) 
esophageal motor activity was assessed by combined intraluminal multiple manometry and 
transmucosal PD-measurements. The methodology using the PD-step up (the difference in PD 
between esophageal and gastric mucosa) to measure the longitudinal muscular contraction 
seems to be of great value. However, occasional presence of H+ in the esophageal lumen will 
influence PD, so the results obtained during acid reflux must be interpreted with care. 
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Interestingly, both the primary peristaltic contraction and the length of the HPZ were inhibited 
by pre-treatment with the AT, receptor blocker candesartan. This compound was ingested as a 
single dose of 16 mg 10-12 h before recordings. This time and dose was chosen based on 
previously reports on plasma concentration and functional AT, receptor interference (the 
latter assessed as effects on renin-release) (Gleiter et al 2002, Azizi et al 2004). Although 
distinct effects on esophageal circular muscle activity were discovered, it appears unlikely 
that candesartan and related compounds influence esophageal motor functions to any 
considerable degree. However, studies on long-term administration of these commonly 
prescribed drugs focusing on esophageal disorders have so far not been conducted. 
Interactions between juxtamucosal NO and RAS in the esophagus? 
The RAS interacts with NO-dependent regulation on several levels. For example effects of 
AT, receptor activation in several organ system have been reported to lead to bradykinin 
release in turn activating the L-arg./NO pathway (Siragy et al 1996, Siragy et al 1997, Berry 
et al 2001, Gohlke et al 1998). In the kidney NO formation may also be stimulated directly via 
AT-, stimulation, independent of bradykinin (Volpe et al 2003). In the small intestine AT2 
receptor activation increases fluid and sodium absorption and this process is dependent on NO 
and subsequent cGMP formation (Jin et al 1999). Both bradykinin and mucosal NO formation 
have been shown to regulate duodenal mucosal alkaline secretion (Chen et al 1997, Holm et al 
2001). Previous studies in our group have shown that duodenal mucosal alkaline secretion can 
be stimulated by the AT2 receptor agonist CGP42112A and inhibited by AT2 receptor 
antagonist PD123319 (Chen et al 1997, Ewert et al 2003). Fuithermore, AT, receptors were 
reported to be located in the duodenal mucosa/submucosa (Johansson et al 2001). AT2-
mediated duodenal alkaline secretion was proposed to be mediated via bradykinin, via BK2 
receptor situated in the duodenal crypt epithelium although a direct link to NO was not 
reported (Ewert et al 2003). 
It can thus be speculated that interactions between AT, receptors and L-arg/NO pathway 
occur also in the esophagus. Immunoreactivities to both AT, and AT, receptors were found in 
the wall of small blood vessels supplying the epithelium and the muscle layers (III), 
suggesting involvement of Ang II in the regulation of local microcirculation, an action where 
NO is involved in (Anggard 1994, Sandler et al 1993). AT, and AT2receptors were also found 
in the epithelium (III) where NOS-dependent liberation of NO also was found (I). Ang II 
stimulates growth and/or proliferative responses via the AT, receptor in various tissues, 
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actions that are counterbalancing by the AT2 receptor (de Gasparo et al 2000). In addition, the 
AT2 receptor promotes apoptosis in a wide diversity of cell types (Volpe et al 2003), an ability 
that NO also has (Shen et al 1998). Endogenous NO formation contributes to low intercellular 
permeability, by affecting the intercellular tight junctions (Salzman et al 1995) and, as 
mentioned above, is involved in the alkaline neutralisation by the duodenal mucosa (Holm et 
al 2001). It may thus be speculated that Ang II via AT! and AT, receptors exert tissue 
remodelling (cellular growth/differentiation/ion transport/tight junction/apoptosis), an action 
most likely also involving the L-Arg/NO pathway in human esophageal epithelium. 
Epilogue 
The present thesis is the result of an integrative physiological approach and points at the 
existence of two regulatory systems, juxtamucosal nitric oxide (NO) generation and the renin-
angiotensin system (RAS) in normal human esophagus. Further studies are needed to 
elucidate the functional potential of these regulatory systems during various physiological 
conditions. Since gastroesophageal reflux disease (GERD) is very common and has great 
input on quality of life, the pathophysiology for this disorder is of much interest. Research 
concerning presence and function of the nitric oxide system and RAS, in relation to GERD is 
strongly recommended. 
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